Muscular Dystrophy Trial, Recruiting (NCT06911190)

Muscular Dystrophy Trial, Recruiting NCT06911190 Sponsor: Radboud University Medical Center Condition: Muscular Dystrophy

Printed from Voxsanity (voxsanity.com.au) — NCT06911190 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Muscular Dystrophy

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You previously took part in the FSHD-FOCUS 2 study and have a genetically confirmed diagnosis of FSHD (facioscapulohumeral muscular dystrophy), and you have been told about this genetic confirmation.
You previously took part in the FSHD-iFocus study as a child/young person and have a genetically confirmed diagnosis of FSHD, and you have been told about this genetic confirmation.
You are a newly enrolling participant who can provide genetic proof of an FSHD diagnosis.

Who may not be able to join:

People who are not able to make decisions for themselves (for example, due to a mental incapacity) are not able to take part.
People who are currently taking part in a medication (drug) trial are not able to join.
If you have certain metal implants or devices in your body (such as a pacemaker, cochlear implant, stents, prosthetic heart valves, or metal fragments in the eye, among others), you would not be able to have the MRI scan part of the study, but you may still be able to participate in other parts of the trial (confirm with trial site).
If you have kidney problems, a known allergy to contrast dye, or claustrophobia (fear of enclosed spaces), you would not be able to have the MRI scan, but you may still be able to take part in other parts of the trial (confirm with trial site).

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 0686550949

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06911190

Sponsor: Radboud University Medical Center

Phase: Not Applicable

Status: Recruiting

Condition: Muscular Dystrophy

Trial contact: 0686550949

More information: https://clinicaltrials.gov/study/NCT06911190

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You previously took part in the FSHD-FOCUS 2 study and have a genetically confirmed diagnosis of FSHD (facioscapulohumeral muscular dystrophy), and you have been told about this genetic confirmation.
You previously took part in the FSHD-iFocus study as a child/young person and have a genetically confirmed diagnosis of FSHD, and you have been told about this genetic confirmation.
You are a newly enrolling participant who can provide genetic proof of an FSHD diagnosis.

Who may not be able to join:

People who are not able to make decisions for themselves (for example, due to a mental incapacity) are not able to take part.
People who are currently taking part in a medication (drug) trial are not able to join.
If you have certain metal implants or devices in your body (such as a pacemaker, cochlear implant, stents, prosthetic heart valves, or metal fragments in the eye, among others), you would not be able to have the MRI scan part of the study, but you may still be able to participate in other parts of the trial (confirm with trial site).
If you have kidney problems, a known allergy to contrast dye, or claustrophobia (fear of enclosed spaces), you would not be able to have the MRI scan, but you may still be able to take part in other parts of the trial (confirm with trial site).

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Radboud University Medical Center

Registry

ClinicalTrials.gov

Start date

1 September 2024

Est. completion

30 December 2025

Where this trial is recruiting

🇳🇱 Netherlands

Primary endpoints

Sensitivity to change; Imaging; Predict disease progression

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov